X-108157242-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_033641.4(COL4A6):āc.4831G>Cā(p.Glu1611Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000554 in 1,208,610 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000045 ( 0 hom., 3 hem., cov: 23)
Exomes š: 0.000057 ( 0 hom. 19 hem. )
Consequence
COL4A6
NM_033641.4 missense
NM_033641.4 missense
Scores
2
9
6
Clinical Significance
Conservation
PhyloP100: 7.91
Genes affected
COL4A6 (HGNC:2208): (collagen type IV alpha 6 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2887656).
BS2
High Hemizygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL4A6 | NM_033641.4 | c.4831G>C | p.Glu1611Gln | missense_variant | 45/45 | ENST00000334504.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL4A6 | ENST00000334504.12 | c.4831G>C | p.Glu1611Gln | missense_variant | 45/45 | 5 | NM_033641.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000447 AC: 5AN: 111874Hom.: 0 Cov.: 23 AF XY: 0.0000881 AC XY: 3AN XY: 34040
GnomAD3 genomes
AF:
AC:
5
AN:
111874
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34040
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000275 AC: 5AN: 181553Hom.: 0 AF XY: 0.0000302 AC XY: 2AN XY: 66263
GnomAD3 exomes
AF:
AC:
5
AN:
181553
Hom.:
AF XY:
AC XY:
2
AN XY:
66263
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000565 AC: 62AN: 1096736Hom.: 0 Cov.: 31 AF XY: 0.0000525 AC XY: 19AN XY: 362198
GnomAD4 exome
AF:
AC:
62
AN:
1096736
Hom.:
Cov.:
31
AF XY:
AC XY:
19
AN XY:
362198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000447 AC: 5AN: 111874Hom.: 0 Cov.: 23 AF XY: 0.0000881 AC XY: 3AN XY: 34040
GnomAD4 genome
AF:
AC:
5
AN:
111874
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34040
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.4834G>C (p.E1612Q) alteration is located in exon 45 (coding exon 45) of the COL4A6 gene. This alteration results from a G to C substitution at nucleotide position 4834, causing the glutamic acid (E) at amino acid position 1612 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 23, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 1612 of the COL4A6 protein (p.Glu1612Gln). This variant is present in population databases (rs774819718, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with COL4A6-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL4A6 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.;.;T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;.;.;.;.
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.;N;.;.
REVEL
Uncertain
Sift
Benign
T;T;.;T;.;.
Sift4G
Benign
T;T;T;T;T;T
Polyphen
D;D;.;D;.;.
Vest4
MutPred
0.38
.;Gain of helix (P = 0.1736);.;.;.;.;
MVP
MPC
0.29
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at